Dr Rafael E Alonso Godinez, MD in Caquas, PR - Medicare Obstetrics/gynecology

Dr Rafael E Alonso Godinez, MD is a medicare enrolled "Obstetrics & Gynecology - Gynecology" physician in Caquas, Puerto Rico. He went to Ponce School Of Medicine and graduated in 1987 and has 37 years of diverse experience with area of expertise as Obstetrics/gynecology. His current practice location is Urb. San Alfonso, Ave. Degetau A-18, Caquas, Puerto Rico. You can reach out to his office (for appointments etc.) via phone at (787) 744-4844.

Dr Rafael E Alonso Godinez is licensed to practice in Puerto Rico (license number 10502) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1154494870.

Contact Information

	Dr Rafael E Alonso Godinez, MD
	Urb. San Alfonso, Ave. Degetau A-18, Caquas, PR 00725
	(787) 744-4844
	(787) 744-4948

Physician's Profile

Full Name	Dr Rafael E Alonso Godinez
Gender	Male
Speciality	Obstetrics/gynecology
Experience	37 Years
Location	Urb. San Alfonso, Caquas, Puerto Rico
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Rafael E Alonso Godinez attended and graduated from Ponce School Of Medicine in 1987

NPI Data:

NPI Number: 1154494870
Provider Enumeration Date: 11/17/2006
Last Update Date: 11/28/2012

Medicare PECOS Information:

PECOS PAC ID: 6103844014
Enrollment ID: I20051109000798

Medical Identifiers

Medical identifiers for Dr Rafael E Alonso Godinez such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1154494870	NPI	-	NPPES
83484	Other	PR	TRIPLE S
064985	Other	PR	CRUZ AZUL

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207VG0400X	Obstetrics & Gynecology - Gynecology	10502 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Rafael E Alonso Godinez is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Rafael E Alonso Godinez, MD #301 Calle Palma De Mallorca, Mansiones De Ciudad Jardin Bairoa, Caquas, PR 00727-1400 Ph: (787) 744-4844	Dr Rafael E Alonso Godinez, MD Urb. San Alfonso, Ave. Degetau A-18, Caquas, PR 00725 Ph: (787) 744-4844

News Archive

Transitions to injecting drug use among noninjecting heroin users

In a study reported in the current issue of the Journal of Acquired Immune Deficiency Syndromes, scientists from the National Development and Research Institutes, Inc. (NDRI) report on a study of street-recruited heroin users in New York City, who were not injecting, to determine the incidence and predictors of making a transition to injecting.

First study to examine links between neurodevelopmental disorders and maternal metabolic conditions

A major study of the relationships between maternal metabolic conditions and the risk that a child will be born with a neurodevelopmental disorder has found strong links between maternal diabetes and obesity and the likelihood of having a child with autism or another developmental disability.

Research shows IQGAP1 as a common target in variants of triple negative breast cancer

The cover for issue 26 of Oncotarget features Figure 6, "Mislocalization of IQGAP1-BRCA1 in human TNBC tumors phenocopies the dominant mutants and the TNBC cells," by Osman, et al. and reported that IQGAP1 is a signaling scaffold implicated in TNBC, but its mechanism is unknown.

EMA CHMP issues negative opinion against Biogen Idec's FAMPYRA for multiple sclerosis

Biogen Idec announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a negative opinion recommending against approval of FAMPYRA to improve walking ability in adult patients with multiple sclerosis (MS) in the European Union. Biogen Idec intends to appeal this opinion and request a re-examination of the decision by the CHMP.

Dr Rafael E Alonso Godinez, MD - Medicare Obstetrics/gynecology in Caquas, PR